Identification of signaling pathways associated with cancer protection in Laron syndrome
Autor: | Rive Sarfstein, Zvi Laron, Lena Lapkina-Gendler, David Gurwitz, Itai Rotem, Metsada Pasmanik-Chor, Haim Werner |
---|---|
Rok vydání: | 2016 |
Předmět: |
Adult
endocrine system Cancer Research medicine.medical_specialty Sp1 Transcription Factor Endocrinology Diabetes and Metabolism Apoptosis 030209 endocrinology & metabolism Growth hormone receptor Biology Cell Line Receptor IGF Type 1 03 medical and health sciences 0302 clinical medicine Endocrinology Neoplasms Internal medicine Autophagy Laron syndrome medicine Humans Insulin-Like Growth Factor I Extracellular Signal-Regulated MAP Kinases Cell Proliferation Insulin-like growth factor 1 receptor Cell Cycle PTEN Phosphohydrolase Cancer Receptors Somatomedin Middle Aged Cell cycle medicine.disease Phenotype Laron Syndrome Oncology 030220 oncology & carcinogenesis Metabolic control analysis Cancer research Female Signal transduction Transcriptome Proto-Oncogene Proteins c-akt Signal Transduction |
Zdroj: | Endocrine-Related Cancer. 23:399-410 |
ISSN: | 1479-6821 1351-0088 |
Popis: | The growth hormone (GH)–insulin-like growth factor-1 (IGF1) pathway emerged in recent years as a critical player in cancer biology. Enhanced expression or activation of specific components of the GH–IGF1 axis, including the IGF1 receptor (IGF1R), is consistently associated with a transformed phenotype. Recent epidemiological studies have shown that patients with Laron syndrome (LS), the best-characterized entity among the congenital IGF1 deficiencies, seem to be protected from cancer development. To identify IGF1-dependent genes and signaling pathways associated with cancer protection in LS, we conducted a genome-wide analysis using immortalized lymphoblastoid cells derived from LS patients and healthy controls of the same gender, age range, and ethnic origin. Our analyses identified a collection of genes that are either over- or under-represented in LS-derived lymphoblastoids. Gene differential expression occurs in several gene families, including cell cycle, metabolic control, cytokine–cytokine receptor interaction, Jak-STAT signaling, and PI3K-AKT signaling. Major differences between LS and healthy controls were also noticed in pathways associated with cell cycle distribution, apoptosis, and autophagy. Our results highlight the key role of the GH–IGF1 axis in the initiation and progression of cancer. Furthermore, data are consistent with the concept that homozygous congenital IGF1 deficiency may confer protection against future tumor development. |
Databáze: | OpenAIRE |
Externí odkaz: |